Aktie A0M4JP SHANDONG PHARMACEUTICAL GLASS CO.LTD
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Shandong Pharmaceutical Glass Co.Ltd

Aktien

A0M4JP

CNE000001BG9

600529

Schlusskurs Shanghai S.E.
Andere Börsenplätze
 00:00:00 28.05.2024 		% 5 Tage % 1. Jan.
26,3 CNY -1,98 % Intraday Chart für Shandong Pharmaceutical Glass Co.Ltd -4,68 % +2,73 %
22.04. Shandong Pharmaceutical Glass Co.Ltd berichtet über die Ergebnisse für das erste Quartal bis zum 31. März 2024 CI
2023 Shandong Pharmaceutical Glass Co.Ltd meldet Ergebnis für die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Shandong Pharmaceutical Glass Co.Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
Shandong Pharmaceutical Glass Co., Ltd announced that it has received CNY 1.866494692 billion in funding
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
Triumph Science & Technology Co.,Ltd cancelled the acquisition of a 11% stake in Shandong Pharmaceutical Glass Co., Ltd from Shandong Luzhong Investment Co., Ltd.
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
Shandong Pharmaceutical Glass Co., Ltd(SHSE:600529) added to Shanghai Stock Exchange Health Care Sector Index
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021
Shandong Pharmaceutical Glass Co., Ltd announced that it expects to receive CNY 1.8664947 billion in funding
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2021
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Fourth Quarter Ended December 31, 2020
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020
Shandong Pharmaceutical Glass Co., Ltd(XSSC:600529) added to FTSE All-World Index
Shandong Pharmaceutical Glass Co., Ltd(XSSC:600529) added to S&P Global BMI Index
Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2020
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A0M4JP Aktie
  4. Nachrichten Shandong Pharmaceutical Glass Co.Ltd
  5. Andere Sprachen